These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 20609658

  • 21. Management of pulmonary arterial hypertension in children.
    Roofthooft MT, van Loon RL, Berger RM.
    Paediatr Respir Rev; 2010 Dec; 11(4):240-5. PubMed ID: 21109183
    [Abstract] [Full Text] [Related]

  • 22. Pulmonary arterial hypertension in the pediatric age.
    Donti A, Formigari R, Ragni L, Manes A, Galiè N, Picchio FM.
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
    [Abstract] [Full Text] [Related]

  • 23. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ, Escribano P, Alonso R, Delgado J, Carreira P, Velazquez T, Sanchez MA, Sáenz de la Calzada C.
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [Abstract] [Full Text] [Related]

  • 24. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
    Clements PJ, Tan M, McLaughlin VV, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Langer A, Pulmonary Arterial Hypertension Quality Enhancement Research Initiative (PAH-QuERI) Investigators.
    Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
    [Abstract] [Full Text] [Related]

  • 25. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C, Escribano Subias P, Tello de Meneses R, Delgado Jiménez JF, Sadia Pérez D, Velázquez Martín MT, Gómez Sánchez MA, Sáenz de la Calzada C.
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pulmonary arterial hypertension in human immunodeficiency virus infection.
    Talwar A, Sarkar P, Rosen MJ.
    Postgrad Med; 2009 Sep; 121(5):56-67. PubMed ID: 19820275
    [Abstract] [Full Text] [Related]

  • 28. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension.
    Theo Schermuly R, Ardeschir Ghofrani H, Weissmann N.
    Curr Top Dev Biol; 2005 Sep; 67():251-84. PubMed ID: 15949537
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ, Escribano P, Delgado JF, Jiménez C, Tello R, Gómez MA, de la Calzada CS.
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [Abstract] [Full Text] [Related]

  • 30. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D, Shitrit D, Kramer MR.
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [Abstract] [Full Text] [Related]

  • 31. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ, Jing ZC, Zhang JH, Wu Y, Wang Y, Jiang X, Wang ZX, Sun YG, Pu JL, Yang YJ.
    Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
    [Abstract] [Full Text] [Related]

  • 32. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition.
    Duffels M, van Loon L, Berger R, Boonstra A, Vonk-Noordegraaf A, Mulder B.
    Congenit Heart Dis; 2007 Oct; 2(4):242-9. PubMed ID: 18377475
    [Abstract] [Full Text] [Related]

  • 33. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM, van Loon RL, Hoendermis ES, Vonk-Noordegraaf A, Roofthooft MT, Talsma MD, Hillege HL, Berger RM.
    Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
    [Abstract] [Full Text] [Related]

  • 34. Endothelin receptor antagonists for pulmonary arterial hypertension: an overview.
    Raja SG.
    Cardiovasc Ther; 2010 Oct; 28(5):e65-71. PubMed ID: 20406243
    [Abstract] [Full Text] [Related]

  • 35. Pediatric pulmonary hypertension in the Netherlands: epidemiology and characterization during the period 1991 to 2005.
    van Loon RL, Roofthooft MT, Hillege HL, ten Harkel AD, van Osch-Gevers M, Delhaas T, Kapusta L, Strengers JL, Rammeloo L, Clur SA, Mulder BJ, Berger RM.
    Circulation; 2011 Oct 18; 124(16):1755-64. PubMed ID: 21947294
    [Abstract] [Full Text] [Related]

  • 36. The use of combination therapy in pulmonary arterial hypertension: new developments.
    Galiè N, Negro L, Simonneau G.
    Eur Respir Rev; 2009 Sep 18; 18(113):148-53. PubMed ID: 20956135
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.
    Bishop BM, Mauro VF, Khouri SJ.
    Pharmacotherapy; 2012 Sep 18; 32(9):838-55. PubMed ID: 22806762
    [Abstract] [Full Text] [Related]

  • 39. Endothelin receptor antagonists -- their role in pulmonary medicine.
    Boniface S, Reynaud-Gaubert M.
    Rev Mal Respir; 2011 Oct 18; 28(8):e94-e107. PubMed ID: 22099418
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.